What does the global healthcare investment landscape look like? Where are the opportunities and how do they differ between Europe and emerging markets? With almost 100 delegates from Asia and dozens from other emerging markets at HBI 2018, our conference this year was global in outlook. Rothschild's head of Healthcare Services Hedley Goldberg summarised the global financial landscape for healthcare investment while local operators and investors shared where they think the opportunities lie. [+]
Australia-based global investment group AMP Capital bought The Regard Group, a UK-based specialist care business, at the end of last year. Healthcare Europa catches up with Ruben Bhagobati, who heads up the company's infrastructure investment arm in Europe, to find out why he thinks the European specialist care market is the one to watch. [+]
Recruitment, retention and training are now the primary challenges for the healthcare services industry. The obvious solution to keeping staff - paying more – is no longer working. Private operators around the world are now fishing in a global market that's short of 15m healthcare workers. So what practical solutions are operators putting into force and what really works? We talk to 25 operators from across the world. [+]
Ali Parsa, the entrepreneurial founder of digital healthcare company babylon, is happy to work with operators – but he doesn’t think it’s necessary or always the best option, as his recent agreement with Chinese social media and messaging giant WeChat shows. Healthcare Europa caught up with him at HBI 2018 to find out more. [+]
Brasil Senior Living (BSL) is establishing a network of elderly and assisted living homes in Brazil - and currently has little by way of organised opposition there. Healthcare Nova talks to CEO and co-founder Ricardo Soares about his plans for the future, why he'd welcome a rival, and what he makes of Orpea's plans to enter the market.
[+]
The Chinese government is promoting traditional Chinese medicine globally, and is authorising payments from insurers for certain treatments. Despite that support, it still faces an uphill battle abroad. Healthcare Nova speaks to a market source. [+]
